OKYO Pharma is listed on NASDAQ.
Securities in Issue
OKYO Pharma issued share capital consists of 32,691,250 ordinary shares of no par value.
Percentage of shares not in public hands is approximately 34.84%
Holdings of Significant Shareholders
As of 4 December 2023 OKYO Pharma is aware of the following persons who hold, directly or indirectly, voting rights representing 5% or more of the issued share capital of OKYO Pharma to which voting rights are attached:
|Name||No. of shares||% of issued share capital|
|Panetta Partners Limited||8,685,367||26.57%|
These shareholdings may differ from those shown on external electronic platforms, which are based solely on shareholder disclosures, because (i) fund managers may hold shares in multiple separate funds where part holdings are considered below disclosure requirement levels, (ii) fund managers may not hold all of the voting rights of the shares and (ii) external electronic platforms may not be up-to-date with new shareholder positions.